Makaila Heifner, Editorial Associate
EDITORIAL ASSOCIATE
Makaila was diagnosed with Type 1 diabetes at 16 months old. Before joining the Beyond Type 1 team in 2019, she worked at several diabetes camps, including Camp Leo and DYF. Makaila earned her BA in Global Studies and a minor in Public Policy from the University of California, Berkeley. When she isn’t editing articles, Makaila is a fan of soup, public radio, and live music. Check her out on Instagram: @makailaheifner.
Written by Makaila
Study Finds Lilly’s Tirzepatide Reduces A1C and Body Weight
After a 40-week treatment plan, a study conducted by Eli Lilly and Company’s found that their new medication tirzepatide significantly reduced A1C and body weight in adults with Type 2 diabetes.MORE
Amazon Launches Online Pharmacy
Amazon Pharmacy, launched on November 17, delivers medications and prescription refills - such as insulin - with Prime membership 2-day shipping.MORE
